Press "Enter" to skip to content

Hematology Diagnostics Market: Industry Analysis, Opportunity Assessment and Forecast up size COVID-19 2026

Global Hematology Diagnostics Market was valued US$3.41 Bn in 2017 and is estimated to reach US$5.98 Bn by 2026 at a CAGR of 7.27%.

 

Hematology diagnostics market is segmented by product type, hematology consumables, end user, and region. Based on end user hematology diagnostics market is classified into hospitals & clinics, diagnostic laboratories, academic institute, commercial service providers, and others. Commercial service providers is estimated to hold the highest share of market due to rising awareness for hematology testing, automated testing, efficient cost and management.
Hematology consumables segment lead the market during forecast period due to increasing awareness of blood disorders among healthcare specialists will grow the demand for hematology analyzers.

Request for Report Sample: https://www.trendsmarketresearch.com/report/sample/10437

Rising the blood donation, increasing incidents of blood disorders, disease like blood cancer and awareness regarding disorders of blood, technical advancements in blood analyzers, rising demand for hematology diagnostics from patients are major drivers of hematology diagnostics market and at same time lack of awareness, growing penetration of POC testing hematology analyzers in emerging economies, high cost of diagnostics and poor insurance for diagnostics will hamper the market.

In terms of region, North America is hold the largest share of the market hematology diagnostics in forecast period due to rising developments of automated technologies in instruments, rising the healthcare infrastructure and analysis blood product quality. Followed by Europe, Asia Pacific, Middle East & Africa, and Latin America.

Key player’s studies, analyzed, profiled and benchmarked in hematology diagnostics market are Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche Ltd., Beckman Coulter Inc., Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Siemens Healthineers, HORIBA, HemoCue AB, Danaher, Nihon Kohden Corporation, Boule Diagnostics, BioSystems, Diatron, Drew Scientific, EKF Diagnostics, Mindray, Fluidigm Corporation, Micronit Microfluidics BV, PerkinElmer Inc., Thermo Fisher Scientific Inc., uFluidix, and Ortho Clinical Diagnostics.
Scope of Global Hematology Diagnostics Market:

Request for Report Discount: https://www.trendsmarketresearch.com/report/discount/10437

Global Hematology Diagnostics Market, by Product Type:
Hematology instruments
Hematology analyzer
Fully-automated heamatology analyzer
Semi-automated heamatology analyzer
Flow cytometers
Others
Global Hematology Diagnostics Market, by Hematology Consumables:
Reagents
Stains
Controls & calibrators
Others
Global Hematology Diagnostics Market, by End User:
Hospitals & clinics
Diagnostic laboratories
Academic institute
Commercial service providers
Others
Global Hematology Diagnostics Market, by Region:
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Key Players, Global Hematology Diagnostics Market:
Abbott Laboratories
Sysmex Corporation
F. Hoffmann-La Roche Ltd.
Beckman Coulter Inc.
Bio-Rad Laboratories
Inc.
Mindray Medical International Limited
Siemens Healthineers
HORIBA
HemoCue AB
Danaher
Nihon Kohden Corporation
Boule Diagnostics
BioSystems
Diatron
Drew Scientific
EKF Diagnostics
Mindray
Fluidigm Corporation
Micronit Microfluidics BV
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
uFluidix
Ortho Clinical Diagnostics.

More Info of Impact Covid19@ https://www.trendsmarketresearch.com/report/covid-19-analysis/10437

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Mission News Theme by Compete Themes.